AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiler, H. A.
Right arrow Articles by Atkinson, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiler, H. A.
Right arrow Articles by Atkinson, S. A.
Agricola
Right arrow Articles by Weiler, H. A.
Right arrow Articles by Atkinson, S. A.

American Journal of Clinical Nutrition, Vol 61, 805-811, Copyright © 1995 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Dexamethasone treatment impairs calcium regulation and reduces bone mineralization in infant pigs

HA Weiler, Z Wang and SA Atkinson
Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Calcium and vitamin D metabolism, bone mineralization, and growth were studied in piglets randomly assigned to 15 d of dexamethasone (0.5 mg.kg-1.d-1, orally) or placebo. Growth velocity was significantly reduced by dexamethasone treatment (P < 0.001). Pigs in the dexamethasone group demonstrated lower 45Ca absorption by in situ intestinal perfusion (P < 0.01). Plasma 25-hydroxycholecalciferol (calcidiol) and 1,25-dihydroxycholecalciferol (calcitriol) were lower (P < 0.05) and the urinary ratio of calcium to creatinine was higher (P < 0.05) after 15 d of dexamethasone compared with placebo. Differences between pre- and postosteocalcin (P < 0.01) and pyridinoline (P < 0.01) were higher and wholebody, lumbar, and femur bone mineral density were lower (P < 0.05) in dexamethasone-treated piglets. Dexamethasone- induced reductions in bone mineral mass likely result from reduced vitamin D status, reduced intestinal calcium absorption, elevated urinary calcium loss and direct effects of the steroid on bone. When dexamethasone is used in premature infants to improve lung function, negative effects on growth and bone metabolism could occur.


This article has been cited by other articles:


Home page
J. Virol.Home page
X. Zhang, K. Alekseev, K. Jung, A. Vlasova, N. Hadya, and L. J. Saif
Cytokine Responses in Porcine Respiratory Coronavirus-Infected Pigs Treated with Corticosteroids as a Model for Severe Acute Respiratory Syndrome
J. Virol., May 1, 2008; 82(9): 4420 - 4428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. E. Scholz-Ahrens, G. Delling, B. Stampa, A. Helfenstein, H.-J. Hahne, Y. Acil, W. Timm, R. Barkmann, J. Hassenpflug, J. Schrezenmeir, et al.
Glucocorticosteroid-induced osteoporosis in adult primiparous Gottingen miniature pigs: effects on bone mineral and mineral metabolism
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E385 - E395.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
N S Wood, K Costeloe, A T Gibson, E M Hennessy, N Marlow, and A R Wilkinson
The EPICure study: growth and associated problems in children born at 25 weeks of gestational age or less
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F492 - 500.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
H. A. Weiler, H. Kovacs, C. Murdock, J. Adolphe, and S. Fitzpatrick-Wong
Leptin Predicts Bone and Fat Mass after Accounting for the Effects of Diet and Glucocorticoid Treatment in Piglets
Experimental Biology and Medicine, September 1, 2002; 227(8): 639 - 644.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. A. Weiler and S. C. Fitzpatrick-Wong
Modulation of Essential (n-6):(n-3) Fatty Acid Ratios Alters Fatty Acid Status but Not Bone Mass in Piglets
J. Nutr., September 1, 2002; 132(9): 2667 - 2672.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. C. Fritz, W. E. Ward, S. A. Atkinson, and H. C. Tenenbaum
Tamoxifen Attenuates the Effects of Exogenous Glucocorticoid on Bone Formation and Growth in Piglets
Endocrinology, August 1, 1998; 139(8): 3399 - 3403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by The American Society for Nutrition